24304 Federal Register / Vol. 87, No. 79 / Monday, April 25, 2022 / Notices 

evaluate a contractor’s progress, and 

review payment requests during 

contract administration. The clause was 

previously GSAR 552.236–78 Shop 

Drawings, Coordination Drawings, and 

Schedules. The clause is simplified, 

including removing the requirement for 

a specific number of prints and copies 

of various submittals. This 

simplification will ease the compliance 

burden for the contractor during 

contract administration from the current 

state. 

B. Annual Reporting Burden 

Public reporting burden for GSAR 

552.236–72 Submittals is estimated to 

average .25 hours per response, 

including the time for reviewing 

instructions, searching existing data 

sources, gathering and maintaining the 

data needed, and completing and 

reviewing the collection of information. 

The annual reporting burden is 

estimated as follows: 

Respondents: 890. 

Responses per respondent: 5. 

Total annual responses: 4,452. 

Preparation hours per response: .25. 

Total response burden hours: 1,113. 

C. Public Comments 

Public comments are particularly 

invited on: Whether this collection of 

information is necessary and whether it 

will have practical utility; whether our 

estimate of the public burden of this 

collection of information is accurate and 

based on valid assumptions and 

methodology; ways to enhance the 

quality, utility, and clarity of the 

information to be collected. 

Obtaining Copies of Proposals: 

Requesters may obtain a copy of the 

information collection documents from 

the GSA Regulatory Secretariat Division, 

by calling 202–501–4755 or emailing 

GSARegSec@gsa.gov. 

Jeffrey A. Koses, 

Senior Procurement Executive, Office of 

Acquisition Policy, Office of Governmentwide Policy. 

[FR Doc. 2022–08711 Filed 4–22–22; 8:45 am] 

BILLING CODE 6820–61–P 

OFFICE OF GOVERNMENT ETHICS 

Agency Information Collection 

Activities; Information Collection 

Renewal; Comment Request for OGE 

Form 319 Request for a Medical 

Exception to the Covid–19 Vaccination 

Requirement 

AGENCY: Office of Government Ethics 

(OGE). 

ACTION: Notice and request for 

comments. 

SUMMARY: After publication of this 

second round notice, the Office of 

Government Ethics (OGE) plans to 

request that the Office of Management 

and Budget (OMB) renew its approval 

under the Paperwork Reduction Act for 

an existing information collection, 

entitled the OGE Form 319 Request for 

a Medical Exception to the Covid–19 

Vaccination Requirement. The form was 

originally granted emergency clearance 

on November 19, 2021. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

FOR FURTHER INFORMATION CONTACT: 

Jennifer Matis at the U.S. Office of 

Government Ethics; telephone: 202– 

482–9216; TTY: 800–877–8339; Email: 

jmatis@oge.gov. A copy of the form may 

be obtained, without charge, by 

contacting Jennifer Matis. 

SUPPLEMENTARY INFORMATION: 

Title: Request for a Medical Exception 

to the Covid–19 Vaccination 

Requirement. 

Agency Form Number: OGE Form 

319. 

Abstract: The OGE Form 319 collects 

information necessary to document the 

consideration, decision, and 

implementation of OGE employee 

requests for reasonable accommodation 

from the COVID vaccination 

requirement set forth in Executive Order 

14043, Requiring Coronavirus Disease 

2019 Vaccination for Federal Employees 

(Sept. 9, 2021). 

OMB Control Number: 3209–0011. 

Type of Information Collection: 

Extension of a currently approved 

collection. 

Type of Review Request: Regular. 

Affected public: Medical providers 

who are asked to provide 

documentation in support of an 

employee’s request for a medical 

exception to the requirement for 

COVID–19 vaccination. 

Estimated Annual Number of 

Respondents: 1 (based on an estimate of 

five respondents over a ten year period, 

rounded up). 

Estimated Time per Response: 10 

minutes. 

Estimated Total Annual Cost Burden 

(in dollars): 17. 

A Federal Register Notice with a 60- 

day comment period soliciting 

comments on this information 

collection was published on February 

10, 2022 (87 FR 7838). OGE received 

one response to that notice. The 

comment did not address the substance 

of information collection; it opposed it 

on the basis of the outstanding 

injunction against implementation of 

the vaccination requirement issued 

pursuant to E.O. 14043. As noted in the 

first notice and again below, OGE will 

not process requests for a medical 

exception or request the submission of 

any medical information related to a 

request for an exception pursuant to 

E.O. 14043 while the injunction remains 

in place. But OGE may nevertheless 

receive information regarding a medical 

exception. Therefore, clearance of the 

information collection is necessary. 

Request for Comments: OGE is 

publishing this second round notice of 

its intent to request paperwork 

clearance renewal for the OGE Form 

319. Public comment is invited 

specifically on the need for and 

practical utility of this information 

collection, the accuracy of OGE’s 

burden estimate, the enhancement of 

quality, utility and clarity of the 

information collected, and the 

minimization of burden (including the 

use of information technology). 

Comments received in response will 

become a matter of public record. 

A Notice Regarding Injunctions: The 

vaccination requirement issued 

pursuant to E.O. 14043 is currently the 

subject of a nationwide injunction. 

While that injunction remains in place, 

OGE will not process requests for a 

medical exception from the COVID–19 

vaccination requirement pursuant to 

E.O. 14043. OGE will also not request 

the submission of any medical 

information related to a request for an 

exception from the vaccination 

requirement pursuant to E.O. 14043 

while the injunction remains in place. 

But OGE may nevertheless receive 

information regarding a medical 

exception. That is because, if OGE were 

to receive a request for an exception 

from the COVID–19 vaccination 

requirement pursuant to E.O. 14043 

during the pendency of the injunction, 

OGE will accept the request, hold it in 

abeyance, and notify the employee who 

submitted the request that 

implementation and enforcement of the 

COVID–19 vaccination requirement 

pursuant to E.O. 14043 is currently 

enjoined and that an exception therefore 

is not necessary so long as the 

injunction is in place. In other words, 

during the pendency of the injunction, 

any information collection related to 

requests for medical exception from the 

COVID–19 vaccination requirement 

pursuant to E.O. 14043 is not 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 87, No. 79 / Monday, April 25, 2022 / Notices 24305 

undertaken to implement or enforce the 

COVID–19 vaccination requirement. 

Approved: April 20, 2022. 

Emory Rounds, 

Director, U.S. Office of Government Ethics. 

[FR Doc. 2022–08754 Filed 4–22–22; 8:45 am] 

BILLING CODE 6345–03–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–22–0978] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled ‘‘Emerging 

Infections Program (EIP)’’ to the Office 

of Management and Budget (OMB) for 

review and approval. CDC previously 

published a ‘‘Proposed Data Collection 

Submitted for Public Comment and 

Recommendations’’ notice on January 

31, 2022, to obtain comments from the 

public and affected agencies. CDC did 

not receive comments related to the 

previous notice. This notice serves to 

allow an additional 30 days for public 

and affected agency comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

Emerging Infections Program (OMB 

Control No. 0920–0978, Exp. 4/30/ 

2022)—Revision—National Center for 

Emerging and Zoonotic Infectious 

Diseases (NCEZID), Centers for Disease 

Control and Prevention (CDC). 

Background and Brief Description 

The Emerging Infections Programs 

(EIPs) are population-based centers of 

excellence established through a 

network of state health departments 

collaborating with academic 

institutions; local health departments; 

public health and clinical laboratories; 

infection control professionals; and 

healthcare providers. EIPs assist in 

local, state, and national efforts to 

prevent, control, and monitor the public 

health impact of infectious diseases. 

Activities of the EIPs fall into the 

following general categories: (1) Active 

surveillance; (2) applied public health 

epidemiologic and laboratory activities; 

(3) implementation and evaluation of 

pilot prevention/intervention projects; 

and (4) flexible response to public 

health emergencies. These activities are 

designed to: (1) Address issues that the 

EIP network is particularly suited to 

investigate; (2) maintain sufficient 

flexibility for emergency response and 

new problems as they arise; (3) develop 

and evaluate public health interventions 

to inform public health policy and 

treatment guidelines; (4) incorporate 

training as a key function; and (5) 

prioritize projects that lead directly to 

the prevention of disease. 

A Revision is being submitted to make 

existing collection instruments clearer 

and to add several new forms 

specifically surveying laboratory 

practices. These forms will allow the 

EIP to better detect, identify, track 

changes in laboratory testing 

methodology, gather information about 

laboratory utilization in the EIP 

catchment area to ensure that all cases 

are being captured, and survey EIP staff 

to evaluate program quality. 

Total estimated burden is 61,956 

hours. There is no cost to respondents 

other than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

State Health Department.ABCs Case Report Form ................................................................... 10 809 20/60 

ABCs Invasive Pneumococcal Disease in Children and Adults Case 

Report Form.

10 127 10/60 

ABCs H.influenzae Neonatal Sepsis Expanded Surveillance Form .. 10 6 10/60 

ABCs Severe GAS Infection Supplemental Form .............................. 10 136 20/60 

ABCs Neonatal Infection Expanded Tracking Form .......................... 10 37 20/60 

FoodNet Campylobacter ..................................................................... 10 970 21/60 

FoodNet Cyclospora ........................................................................... 10 42 10/60 

FoodNet Listeria monocytogenes ....................................................... 10 16 20/60 

FoodNet Salmonella ........................................................................... 10 855 21/60 

FoodNet Shiga toxin producing E. coli ............................................... 10 290 20/60 

FoodNet Shigella ................................................................................ 10 234 10/60 

FoodNet Vibrio .................................................................................... 10 46 10/60 

FoodNet Yersinia ................................................................................ 10 55 10/60 


khammond on DSKJM1Z7X2PROD with NOTICES